Shenzhen MicroApproach Medical Technology CO., LTD. is a Chinese leading manufactuer and exporter of medical devices in the fields of Urology, Gastroenterology , Cardiology Intervention & Peripheral Intervention. Founded in 2015, we have gathered senior R&D engineers from Japan and China in the intervention medical solution industry. MicroApproach provides high-quality Medical Consumables from China, to the world at affordable prices.
Headquartered in Shenzhen, China, R&D center located in Tokyo, Japan, MicroApproach has a production base of 10,000 square meters in Shenzhen, of which the area of GMP is more than 6000 square meters. MicroApproach has obtained the ISO13485 international quality system certification for medical devices issued by German TUV. Many products had obtained CE & NMPA certificates. Our products currently reach hospitals and patients in over 20 countries.
Certificate
The company has obtained the ISO13485 international quality system certification for medical devices issued by German TUV. Many products had passed CE and NMPA certifications and have independent intellectual property rights.
Target Market
Hunan
Shenzhen
HongKong
Tokyo
Mexico
Argentina
France
Turkey
Egypt
Sudan
Nigeria
Thailand
Sri Lanka
South Korea
Brazil
Germany
Italy
Jordan
Saudi Arabia
UAE
India
Vietnam
Malaysia
Japan
Corporate Milestones
2015
Founded in
2018
ISO13485 certified CE certificates
2019
National High-tech Enterprise Japan R&D center setup
2022
30+ products launched Whole solution for intervention therapy
2024
National Specialized, Innovative and Small Giant Enterprise
2025
Global leading interventional access platform enterprise
Quality System
Many products had obtained CE & NMPA certificates. Our products currently reach hospitals.
High Quality Medical
Shenzhen Minimally Invasive Medical is a leading medical device manufacturer and exporter in China.
Affordable Price
MicroApproach provides high-quality Medical Consumables from China, to the world at affordable prices.
Professional Team
Gathered senior R&D engineers from Japan and China in the intervention medical solution industry.